QUINCE THERAPEUTICS INC

Historical 13F Holders

Symbol
QNCX
CUSIP
22053A305
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 22053A305 since 12/18/2024, largest first.

Filer % of Class Filed
Cormorant Asset Management, LP 13G
10.0% 8/14/2026
Event 6/30/2026
Balyasny Asset Management L.P. 13G
10.0% 8/14/2026
Event 6/30/2026
Ikarian Capital, LLC 13G
9.0% 8/14/2026
Event 6/30/2026
Squadron Capital Management LLC 13G
5.6% 8/4/2026
Event 7/28/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Nantahala Capital Management, LLC 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 29 330 k $17.3 M